PGP and osteosarcoma: One of the first studies using the canine osteosarcoma cell line OS2.4 demonstrated that doxorubicin treatment was able to select clones resistant even to vincristine through the overexpression of P-gp, similar to the results obtained in human osteosarcoma cell lines and biopsy specimens [18].